Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.04.2023 | Case report

Antineoplastics

Adrenal insufficiency and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Reiter FP, et al. Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations. Zeitschrift fur Gastroenterologie 61: 71-75, No. 1, Jan 2023. Available from: URL: http://doi.org/10.1055/a-1952-1233 Reiter FP, et al. Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations. Zeitschrift fur Gastroenterologie 61: 71-75, No. 1, Jan 2023. Available from: URL: http://​doi.​org/​10.​1055/​a-1952-1233
Metadaten
Titel
Antineoplastics
Adrenal insufficiency and lack of efficacy: case report
Publikationsdatum
01.04.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-36823-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Nivolumab

Case report

Pembrolizumab

Case report

Tozinameran